Physiologic changes associated with pregnancy, including mechanical, hormonal, and biochemical changes, alterations in sensitivity to bupivacaine, pregnancy-induced heart hypertrophy and changes in cardioprotective signaling cascades (10) may be responsible for the failure of ILP to reliably rescue bupivacaine-induced cardiac arrest in pregnancy. The gene discussed is XIAP; the disease is cardiac arrest.